Pharmacology Flashcards

1
Q

What type of drug is Reslizumab

A

…mab = Monoclonal AntiBody

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What type of drug is Dexamethasone

A

…sone = corticosteroid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What type of drug is Prednisolone

A

…lone = corticosteroid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What type of drug is Salmeterol

A

…terol = bronchodilators

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What type of drug is Nintedanib

A

…nib = kinase iNhIBitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the 2 vital regions of the respiratory system

A

Conducting airways

Respiratory region

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What does the respiratory region consist of

A

Respiratory bronchioles
Alveolar ducts
Alveolar sacs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is most common device used to inhaled respiratory drugs

A

Inhaler

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What device delivers medication in form of an aerosol

A

Nebuliser

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe differences in blood flow between conducting airways and respiratory region

A

Conducting airways - smaller surface area and lower regional blood flow
Respiratory region - accounts for >95% of lungs surface area and is directly connected to the systemic circulation via the pulmonary circulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Deliver systems for inhaled drugs

A

Pressurised metered-dose inhalers (pMDIs)
Spacer devices
Dry powder inhalers (DPIs)
Nebulisers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What causes bronchoconstriction of airways

A

Tightening of airway smooth muscle (ASM)
Lumenal occlusion by mucus and plasma
airway wall thickening

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

In what diseases would you most commonly see bronchoconstriction

A

Asthma

COPD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

2 main categories of treating bronchoconstriction

A

Bronchodilation - adrenergic (sympathetic)

Block bronchoconstriction - anti-cholinergic (parasympathetic)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Examples of bronchodilators

A

Beta 2 Adrenoreceptor Agonists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How do Beta 2 Adrenoreceptor Agonists work

A

Act on B2-adenoreceptors to cause smooth muscle relaxation and bronchodilation
Also inhibits histamine release from lung mast cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Examples of Beta 2 Adrenoreceptor Agonists

A

SABA/Short acting B2-adrenoreceptor agonists
LABA/Long acting B2-adrenoreceptor agonists
ultra-LABA (E.g. Indacaterol - allow once daily dosing)

18
Q

Example of SABA

A

Salbutamol

19
Q

Example of LABA

A

Formoterol and Salmeterol

20
Q

What LABAs combined with in treatment of asthma

A

Inhaled cortiosteroids

21
Q

What are LABAs combined with in treatment of COPD

A

Inhaled Long-acting Anti-Muscarinic Agent (LAMA)

22
Q

What is effect of acetylcholine on airway smooth muscle

A

Contracts ASM by activating muscarinic receptors on smooth muscle cells

23
Q

What is effect of anticholinergics on muscarinic receptors

A

Block ACh binding

24
Q

What is Atropine

A

Naturally occuring anticholinergic found in deadly nightshade
Reverses bronchoconstriction caused by parasympathetic nerve stimulation

25
Q

What is the most effective anti-inflammatory drug for asthma

A

Glucocorticoids

26
Q

Effects of inhaled corticosteroids on asthma

A

improve the quality of life of patients with asthma
improve lung function
reduce frequency of exacerbations
Can prevent irreversible airway changes

27
Q

Examples of Inhaled Corticosteroids

A
Beclomethasone dipropionate (pMDI and DPI)
Budesenide
28
Q

How do inhaled corticosteroids reduce inflammation

A

Reduce numbers of inflammatory cells in airways:
Suppress the production of chemotactic mediators
Reduce adhesion molecule expression
Inhibit inflammatory cell survival in the airway
Suppress inflammatory gene expression in airway epithelial cells

29
Q

Side effects of ICS

A
Reduce SEs by giving at lowest effective dose
Overuse in long-term can cause:
Loss of bone density
Adrenal suppression
Cataracts, glaucoma
30
Q

Corticosteroid resistance in asthma and COPD

A

(Non-eosinophilic) Asthma - approx 10% patients require maximal dose and 1% require regular oral corticosteroids. Small no. patients are completely unresponsive to ICS.

COPD - most patients are resistant to ics

31
Q

Mechanisms of corticosteroid resistance

A

Possible genetic causes – could this allow us to predict which patients will be resistant?
Poor GR binding and nuclear translocation
Reduced downstream cellular signalling following corticosteroid:GR binding

32
Q

*Interactions between B2 agonists and ICS

A

Glucocorticoids increase the transcription of the b2-receptor gene, resulting in increased expression of cell surface receptors.
Long-acting b2-Agonists increase the translocation of GR from cytoplasm to the nucleus after activation by glucocorticoids

This all leads to an overall greater efficacy and need for lower doses

33
Q

What cells largely drive inflammation in allergic asthma

A

Eosinophils

Lymphocytes

34
Q

What is Bronchiectasis

A

Obstructive lung disease
Abnormal dilation of the bronchi - excessive sputum production and chest pain
Associated with cystic fibrosis (but can have non CF bronchiectasis)

35
Q

Treating Bronchiectasis

A

Antibiotics - infective elements
Physical therapy clears airways
Surgery and transplantation in severe cases
Medication

36
Q

Medical treatment bronchiectasis

A

Mucolytics treat hypersecretion
B2 agonists most useful in COPD/asthma/Bronchiectasis overlap syndromes
Anticholinergics and ICS have limited effect

37
Q

Complications of excessive fibrosis

A

excessive fibrous connective tissue leads to permanent scarring, airway wall thickening and breathing difficulties

38
Q

Fibrosis medical treatment

A

Some forms respond to corticosteroids
PIRFENIDONE and NINTEDANIB are new drugs that significantly slow the rate of disease progression in Idiopathic Pulmonary Fibrosis

39
Q

What is Pirfenidone

A

Commonly used antifibrotic in IPF
Anti-fibrotic, Anti-inflammatory and Anti-oxidant properties
Oral

40
Q

Effects of pirfenidone

A

Reduces:
fibroblastproliferation
collagenproduction
production of fibrogenic mediators

41
Q

What is Nintendanib

A

Tyrosine Kinase Inhibitor

42
Q

How does Nintendanib work

A
Tyrosine kinase inhibitor
Inhibits VEGFR (Vascular endothelial growth factor receptor) and other growth factor receptors, which are some of the drivers of the fibrotic process